Vancouver, BC -- (SBWIRE) -- 02/01/2021 -- Market Size – USD 8,067.0 Million in 2019, Market Growth - CAGR of 5.3%, Market Trends –Development of new biomarkers

Cancer can be defined as uncontrolled cell growth in the body, resulting in organ malfunction. If untreated, it can prove fatal. Uncontrolled growth of cells is managed by the body in various ways; one is by deploying WBCs (white blood cells) to detect and eradicate these cancerous cells.

Market Drivers
The global cancer imaging system market is estimated to grow extensively owing to the rising prevalence of various types of cancer, continuous research and development activities from top pharmaceutical companies, and advanced techniques utilized in cancer imaging systems. The increasing prevalence of various types of cancer like prostate, colorectal, lung, and breast cancer is a key factor driving the market growth. Increasing awareness about early detection of cancer among patients, advancements in digital imaging techniques, rising government funding and initiatives, and active support of the government are boosting the global cancer imaging system market.

We Have Recent Updates of Cancer Imaging Systems Market in Sample Copy: https://www.emergenresearch.com/request-sample-form/222

Key participants include GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.

Regional Landscape
On the basis of region, the global cancer imaging system market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Every geographic cancer imaging system market is sub-divided into certain countries like U.S., Canada, U.K., Brazil, Germany, India, China, Japan, and GCC countries. North America emerged as the dominator of the global cancer imaging systems market owing to the early adoption of highly developed technologies in healthcare in the region. The Asia Pacific is expected to be a highly lucrative market during the forecast period owing to the existence of a large patient base and initiatives by governments to undertake various control programs.

Key Highlights From The Report
In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science instrumentation, including cell imaging systems.
MRI offers the benefit of imaging soft body tissue parts that are occasionally hard to view using other types of modalities. MRI is excellent at identifying and locating some cancers. Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor imaging technique.
Lung cancer is a common type of cancer in men and the third-leading cancer type in women with 2 million novel cases in the year 2018. Hungary, Serbia, and New Caledonia (France) were the top three countries with the highest disease rate in 2018.
Diagnostics centers are projected to grow at the fastest rate of 10.0% in the forecast period. Diagnostic centers are fitted out with the requisite imaging system and specialist staff, as well as healthcare personnel, for assisting in the process of detecting diseases in individuals displaying specific symptoms.
The market in the North American region held the largest market share in 2019, owing to a high adoption of advanced imaging technologies, a rising incidence of cancer, established healthcare infrastructure, and undertaking of various initiatives to create awareness about the disease.

Read more@ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)
Mammography
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Positron Emission Tomography (PET)
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Diagnostic Centers
Others

Flow Control Valves market segment by region/country including:
North america (united states, canada and mexico)
Europe (germany, uk, france, italy, russia and spain etc.)
Asia-pacific (china, japan, korea, india, australia and southeast asia etc.)
South america brazil, argentina, colombia and chile etc.)
Middle east & africa (south africa, egypt, nigeria and saudi arabia etc.)

To Know More about Cancer Imaging Systems Market Get Free Sample Copy of this Report @ https://www.emergenresearch.com/request-sample-form/222

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Cancer Imaging Systems Market Segmentation & Impact Analysis
Chapter 5. Cancer Imaging Systems Market By Imaging Systems Insights & Trends, Revenue (USD Million)
Chapter 6. Cancer Imaging Systems Market By Application Insights & Trends Revenue (USD Million)
Chapter 7. Cancer Imaging Systems Market By End-Users Insights & Trends Revenue (USD Million)
Chapter 8. Cancer Imaging Systems Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
Continue…

Reports:
The global Ground Defense System Market size was valued at USD 46.57 billion in 2019 and is anticipated to reach USD 68.28 billion by 2027 at a CAGR of 4.8%.

The global hearing aids market size was valued at USD 5,480.1 Million in 2019 and is forecasted to reach USD 8,967.7 Million by 2027 at a CAGR of 6.3%. 

The Global Human Microbiome Therapeutics Market size was valued at USD 243.0 Million in 2019 and is anticipated to reach USD 1,098.4 Million by 2027 at a CAGR of 22.0%. 

The Global Interventional Cardiology Market size was valued at USD 15.50 Billion in 2019 and is forecasted to reach USD 26.92 Billion by 2027 at a CAGR of 7.6%.

The global Metamaterials Market size was valued at USD 658.3 million in 2019 and is anticipated to reach USD 3.61 billion by 2027 at a CAGR of 23.6%.

The global pharmacovigilance market size was valued at USD 4,820.5 Million in 2019 and is forecasted to reach USD 12.48 Billion by 2027 at a CAGR of 12.5%. 

The Global Photonic Crystals Market size was valued at USD 54.80 Billion in 2019 and is anticipated to reach USD 99.26 Billion by 2027 at a CAGR of 8.2%.

The Global Prefilled Syringes Market size was valued at USD 4.80 Billion in 2019 and is forecasted to reach USD 9.11 Billion by 2027 at a CAGR of 8.9%. 

The global Radiation Dose Management Market size was valued at USD 202.9 million in 2019 and is anticipated to reach USD 505.3 million by 2027 at a CAGR of 12.6%. 

The Global Sugar Substitutes Market size was valued at USD 15.80 Billion in 2019 and is forecasted to reach USD 22.53 Billion by 2027 at a CAGR of 4.8%.

The global magnesia chrome bricks market was valued at USD 2,190.7 Million in 2019 and is projected to reach USD 2,742.9 Million by 2027, at a CAGR of 2.8% during the forecast period. 

The global cast elastomers market size was USD 1,310.4 Million in 2019 and is projected to reach USD 1,842.2 Million by 2027, at a CAGR of 4.3% during the forecast period. 

The global peristaltic pumps market size was USD 1,182.9 Million in 2019 and is projected to reach USD 1,906.8 Million by 2027, at a CAGR of 6.1% during the forecast period. 

The global water treatment biocides market size was USD 3.63 Billion in 2019 and it is anticipated to reach USD 5.74 Billion by 2027, at a CAGR of 6.3% during the forecast period.